Drug
Moxifloxacin clinical trials
Also written Avelox, Vigamox and BAY 12-8039.
Keep track of what changes. Save the Moxifloxacin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- Moxifloxacin
- 116
Development codes
Studies by the year they started
215 studies that test it; most in 2008 (16); 1 more planned to start later
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 8 |
| 2005 | 3 |
| 2006 | 12 |
| 2007 | 14 |
| 2008 | 16 |
| 2009 | 10 |
| 2010 | 13 |
| 2011 | 16 |
| 2012 | 13 |
| 2013 | 11 |
| 2014 | 14 |
| 2015 | 3 |
| 2016 | 7 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 8 |
| 2020 | 8 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 8 |
| 2026 | 7 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
- Cataract
- 10
Who runs them
Industry 105 · Other 112
Bayer (21) · Alcon Research (13) · Global Alliance for TB Drug Development (7) · Centers for Disease Control and Prevention (6) · Boehringer Ingelheim (5) · AstraZeneca (5) · Johns Hopkins University (5) · Merck Sharp & Dohme LLC (4)
Often tested with
Tested in the same studies.
Pyrazinamide (13) · Bedaquiline (11) · Pretomanid (11) · Dexamethasone (11) · Levofloxacin (10) · Rifapentine (7) · Linezolid (7) · Isoniazid (7)
Studies
Open first, then newest update. How each study uses Moxifloxacin is read from its arms, and is right about nine times in ten.
Testing it · 217
- Fluoroquinolone-Doxycycline Oral Treatments for Adults With Uncomplicated BrucellosisNot yet recruitingNot applicableThe First Affiliated Hospital of Shihezi UniversityNCT07887126Written as Doxycycline + Moxifloxacin
- Moxifloxacin Versus Clindamycin in the Management of Odontogenic Maxillofacial Infectious ProcessesNot yet recruitingNot applicableNishtar Medical UniversityNCT07810244Written as Moxifloxacin (400 mg)
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TBRecruitingPhase 2University College, LondonNCT06114628Written as Moxifloxacin (M)
- Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract SurgeryNot yet recruitingPhase 2/3Jason Ahee, M.D.NCT03244072Written as Moxifloxacin
- A Study in Healthy People to Measure How Different Doses of Verducatib Affect the HeartRecruitingPhase 1Boehringer IngelheimNCT07760246Written as Moxifloxacin
- Program for Rifampicin-Resistant Disease With Stratified Medicine for TuberculosisRecruitingPhase 2/3University of California, San FranciscoNCT06441006Written as Moxifloxacin
- Efficacy & Safety of Fluoroquinolone-Based Brucellosis Regimens (BRUCE)Not yet recruitingNot applicableThe First Affiliated Hospital of Shihezi UniversityNCT07779629Written as Doxycycline + Moxifloxacin
- A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)Not yet recruitingPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT07595042Written as Moxifloxacin
- Shortened Regimen for Drug-susceptible TB in ChildrenRecruitingPhase 3Johns Hopkins UniversityNCT06253715Written as Moxifloxacin
- Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective EndocarditisRecruitingPhase 4Fundacion Clinic per a la Recerca BiomédicaNCT05398679Written as Moxifloxacin tablet
- Finding the Optimal Regimen for Mycobacterium Abscessus TreatmentRecruitingPhase 2/3The University of QueenslandNCT04310930Written as Moxifloxacin
- PRO-232 in Patients Subjected to Cataract SurgeryRecruitingPhase 3Laboratorios Sophia S.A de C.V.NCT07305987Written as Moxifloxacin / Dexamethasone Ophthalmic Solution
- Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast CancerRecruitingPhase 3Sun Yat-Sen University Cancer CenterNCT04722978Written as Gemcitabine and carboplatin plus antibiotic (moxifloxacin)
- PanACEA - STEP2C -01RecruitingPhase 2Michael HoelscherNCT05807399Written as Moxifloxacin
- Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible TuberculosisNot yet recruitingPhase 2Shanghai Pulmonary Hospital, Shanghai, ChinaNCT07129629Written as Moxifloxacin
- Short-Course Anti-tuberculosis Regimens for Mild Spinal TuberculosisNot yet recruitingPhase 2Shandong UniversityNCT06917495Written as Moxifloxacin
- Oral Antibiotic Outpatient Therapy vs. Placebo in the Treatment of Uncomplicated Acute AppendicitisNot yet recruitingNot applicableTurku University HospitalNCT06210269Written as Moxifloxacin 400mg
- Intensified Short Course Regimen for TBM in AdultsNot yet recruitingPhase 3Indian Council of Medical ResearchNCT05917340Written as Moxifloxacin 400mg
- Acute Appendicitis and Microbiota - Etiology of Appendicitis and Antibiotic Therapy EffectsEnrolling by invitationNot applicableTurku University HospitalNCT03257423Written as Moxifloxacin
- Effect of Maridebart Cafraglutide on the Heart's Electrical ActivityCompletedPhase 1AmgenNCT07229157Written as Moxifloxacin
See all 217 studies that test Moxifloxacin →
Given in every arm · 59 — Moxifloxacin is usual care beside what is tested
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform TrialNot yet recruitingPhase 2The University of QueenslandNCT07485010Written as moxifloxacin
- A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant TuberculosisNot yet recruitingNot applicableWuhan Pulmonary HospitalNCT07126639Written as Moxifloxacin (M)
- Rose Bengal Electromagnetic Activation With Green Light for Infection ReductionCompletedPhase 3University of California, San FranciscoNCT05110001Written as Moxifloxacin Ophthalmic
- A Study of Soticlestat in Healthy Adults To Evaluate the Effect on QTc IntervalWithdrawnPhase 1TakedaNCT05309902Written as Moxifloxacin
- Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction IIActive, not recruitingPhase 3University of California, San FranciscoNCT06271772Written as Moxifloxacin Ophthalmic
- Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary TuberculosisCompletedPhase 2GlaxoSmithKlineNCT05382312Written as Moxifloxacin
- A Study To Evaluate The Effect Of A Supratherapeutic Dose Of Elpipodect (MK-8189) On The QTc Interval In Participants With Schizophrenia (MK-8189-019)CompletedPhase 1Merck Sharp & Dohme LLCNCT05893862Written as Moxifloxacin
- Staccato Loxapine Thorough QT/QTc StudyCompletedPhase 1Nova Pneuma Inc.NCT00874237Written as Oral moxifloxacin
- A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)CompletedPhase 1Merck Sharp & Dohme LLCNCT07063238Written as Moxifloxacin
- A TQT Study of Effect of M2951 on Cardiac RepolarizationCompletedPhase 1Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT07214935Written as Moxifloxacin
- PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)CompletedPhase 2LigaChem Biosciences, Inc.NCT04550832Written as Bedaquiline, Delamanid, Moxifloxacin
- A TQTc Study for OmaveloxoloneCompletedPhase 1BiogenNCT05927649Written as Moxifloxacin
- Effects of Bromfenac on Macular Thickness After Phacoemulsification SurgeryCompletedPhase 4Inas AbdNCT06785090Written as Moxifloxacin 0.5% ophthalmic solution
- A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT05387759Written as Moxifloxacin
- Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline CohortActive, not recruitingPhase 3Beijing Chest HospitalNCT06081361Written as Moxifloxacin
- Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy AdultsCompletedPhase 1CytokineticsNCT04175808Written as Moxifloxacin
- A Study to Evaluate the Effects of Loperamide (JNJ-289679) on Electrocardiogram Intervals in Healthy Adult ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT04225078Written as Moxifloxacin
- Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT02833831Written as Moxifloxacin
- Steroids and Cross-linking for Ulcer TreatmentCompletedPhase 3Thomas M. LietmanNCT04097730Written as Moxifloxacin Ophthalmic
- A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy ParticipantsCompletedPhase 1Janssen Research & Development, LLCNCT02658825Written as Moxifloxacin
Showing 20 of 59.
As the comparator · 201 — what is tested is compared with Moxifloxacin
- A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult ParticipantsRecruitingPhase 1EpygenixNCT07879170Written as Moxifloxacin
- Intracameral Levofloxacin Versus Moxifloxacin After Cataract SurgeryNot yet recruitingNot applicableAssiut UniversityNCT07850414Written as Moxifloxacin
- A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy SubjectsRecruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07594847Written as Moxifloxacin 400 mg
- A PAN-USR TB Multi-Center TrialRecruitingPhase 3Shenzhen Third People's HospitalNCT06905522Written as Moxifloxacin (M)
- A Study to Evaluate the Effect of XY0206 on the QTc Interval in Chinese Healthy ParticipantsRecruitingPhase 1Shijiazhuang Yiling Pharmaceutical Co. LtdNCT07162116Written as Moxifloxacin (400 mg)
- A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABPRecruitingPhase 3Zai Lab (Hong Kong), Ltd.NCT06162286Written as Moxifloxacin
- Sitafloxacin-containing Regimens for Shortening Tuberculosis TreatmentNot yet recruitingPhase 3First Affiliated Hospital of Zhejiang UniversityNCT05454345Written as Moxifloxacin
- A Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy ParticipantsCompletedPhase 1AmgenNCT06411860Written as Moxifloxacin
- BTZ-043 Dose Evaluation in Combination and SelectionCompletedPhase 2Michael HoelscherNCT05926466Written as Moxifloxacin
- A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD.CompletedPhase 1Guangdong Hengrui Pharmaceutical Co., LtdNCT07116915Written as Moxifloxacin Hydrochloride Tablets
- A Study in Healthy People to Test How Vicadrostat Affects the HeartCompletedPhase 1Boehringer IngelheimNCT07513207Written as Moxifloxacin
- QT Interval/Corrected QT Interval （QT/QTc） Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy ParticipantsActive, not recruitingPhase 1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT07708272Written as Moxifloxacin Hydrochloride Tablets
- A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.CompletedPhase 1SanofiNCT07272629Written as Moxifloxacin
- Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy SubjectsCompletedPhase 1Shanghai Ark Biopharmaceutical Co., Ltd.NCT06591845Written as Moxifloxacin hydrochloride tablet 400 mg
- An Investigational Study to Evaluate the Cardiac Safety Assessment (TQTc Study) of ESK-001CompletedPhase 1Alumis IncNCT07378579Written as Moxifloxacin (400 mg)
- Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)CompletedPhase 1Haisco-USA Pharmaceuticals, Inc.NCT06795204Written as Moxifloxacin Hydrochloride
- A Study on the Effect of Etavopivat on Heart Rhythm in Healthy ParticipantsCompletedPhase 1Novo Nordisk A/SNCT07023029Written as Moxifloxacin
- A Cardiac Liability Study of Varegacestat in Healthy ParticipantsCompletedPhase 1Immunome, Inc.NCT06855264Written as Moxifloxacin 400 mg
- A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT05630274Written as Moxifloxacin
- A Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy AdultsCompletedPhase 1Kaken PharmaceuticalNCT06649942Written as Moxifloxacin 400 mg
Showing 20 of 201.
Codes
What other systems call Moxifloxacin · ClinicalTrials.gg INT006679
- MeSH (NLM) D000077266MoxifloxacinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) U188XYD42PMOXIFLOXACINConfirmed FDA, NLM, Wikidata
- RxNorm 139462Confirmed FDA, Wikidata
- Wikidata Q424940moxifloxacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C62052MoxifloxacinOne source FDA
- DrugBank DB00218One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077266 | Moxifloxacin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | U188XYD42P | MOXIFLOXACIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 139462 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424940 | moxifloxacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C62052 | Moxifloxacin | One source FDA |
| DrugBank | DB00218 | — | One source Wikidata |
Also registered as moxifloxacin hydrochloride (UNII C53598599T · RxNorm 228750).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.